Inventors:
Roy Eagleson - London, CA
Robert Goldsmith - San Francisco CA, US
Michael J. Rieder - London, CA
Ian R. Marshall - Mississauga, CA
Jan Greenhalgh - Burlington, CA
Assignee:
INTERNATIONAL BIO-THERAPEUTIC RESEARCH INC. - Mississauga ON
International Classification:
A61N 1/30, A61K 33/38, A61K 9/12, A61K 9/70, A61K 9/00, A61K 9/48, A61M 5/20, A01G 7/04, A61M 11/00, A61P 31/12, A61P 31/10, A61P 31/04, A61P 35/04
US Classification:
604 21, 424618, 424 43, 424449, 424400, 424451, 604131, 12820023, 47 13
Abstract:
A method for treating a bacterial, viral, fungal, or vector-induced disease state. A therapeutically effective dose of a metal substance is delivered to the body of a potentially infected organism using a delivery methodology selected from the group consisting of syringes, auto-injectors, pricking devices, buccal embedding, transdermal patches, needle transdermal patches, aerosol inhalers, ingestible dissolvable capsules, encapsulated boluses, needle encapsulated boluses, and electrode catheterization methodologies. The metal substance is selected from the group consisting of silver, gold, copper, zinc, selenium, platinum, and their ions, alloys, salts, and combinations thereof. Preferably, an electrical current is introduced substantially in the course of utilizing the delivery methodology. The electrical current is preferably substantially varied over time, and is still more preferably a reversing electrical current.